Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.

Journal of clinical lipidology - 1 Jan 2000

Ibarretxe Daiana, Girona Josefa, Amigó Núria, Plana Núria, Ferré Raimón, Guaita Sandra, Mallol Roger, Heras Mercedes, Masana Luis

Abstract excerpt

BACKGROUND: The role of circulating FABP5 on metabolic alterations is under active evaluation. On the other hand, FABP5 SNPs (rs454550 and rs79370435) seem to modulate its effect. OBJECTIVES: Our aim was to examine the role of circulating FABP5 levels and its main SNPs in atherogenic dyslipidemia (AD) assessed by 2D-Nuclear Magnetic Resonance (NMR) and related metabolic and inflammation markers. We hypothesized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aged
Share to Atherosclerosis
Share to Biomarkers
Share to Dyslipidemias
Share to Fatty Acid-Binding Proteins
Share to Magnetic Resonance Spectroscopy
Share to Polymorphism, Single Nucleotide
Share to Risk Factors

Source

Identifiers

PMID: 27055964
DOI: 10.1016/j.jacl.2015.12.012

Genes

FABP5
FABP4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.PMID 27055964Read ↗

FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants.Semantic proximity Read ↗

Polymorphisms in fatty acid binding protein 5 show association with type 2 diabetes.Semantic proximity Read ↗

Transcriptome analysis revealed FABP5 as a serum marker of metabolic associated fatty liver diseaseSemantic proximity Read ↗

Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population.Semantic proximity Read ↗

Association of fatty acid binding protein-4 (FABP-4) T87C and rs8192688 gene polymorphisms and FABP-4 level with cardiovascular disease susceptibility in type 2 diabetic patients.Semantic proximity Read ↗

APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis.Semantic proximity Read ↗

New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.Semantic proximity Read ↗

Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein.Semantic proximity Read ↗

Clinical significance of apolipoprotein A5.Semantic proximity Read ↗

Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.Semantic proximity Read ↗

The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.Semantic proximity Read ↗

Common FABP4 genetic variants and plasma levels of fatty acid binding protein 4 in older adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.